Vanderbilt Institute for Infection Immunology and Inflammation (VI4)

C. diff captures blood cell cofactor to build defensive shield

Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics.

The adaptable anthrax bacterium

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Richard Locksley, MD, right, spoke about his allergic diseases research during his recent Flexner Discovery Lecture. Here, he poses for a photo with VUMC’s Eric Skaar, PhD, MPH.

Locksley’s Discovery Lecture

Richard Locksley, MD, spoke about his allergic diseases research during his recent Flexner Discovery Lecture. Here, he poses for a photo with VUMC’s Eric Skaar, PhD, MPH.

Zinc uptake by a deadly pathogen

The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses.

Wexler receives Helen Hay Whitney Foundation Fellowship

Aaron Wexler, PhD, a research fellow in the Department of Pathology, Microbiology and Immunology, has received a Helen Hay Whitney Foundation Fellowship.

Imaging host-pathogen battle for metal

An unprecedented view of bacterial products within infected tissues opens new opportunities to explore infection biology and devise novel therapeutic strategies.

1 2 3 4 5